ABSTRACT Background: Taurine is an abundant amino acid in human cells, promoting ocular and biliary health, which is also used to treat congestive heart failure, hypertension, and hepatitis. Recently, the consumption of taurine-enriched energy drinks has become popular with young adults, but taurine effects on serum lipids in young adults are unknown.
INTRODUCTION
Taurine is considered to be a semi-essential amino acid and is the most abundant free intracellular amino acid in human cells [1] . Taurine plays an important role as a basal factor for maintaining cellular integrity in the heart, muscle, retina, and the central nervous system [2] . Physiological effects of taurine supplementation have been reported to include blood pressure lowering [3, 4] , antioxidant and anti-inflammatory actions [5] , and increased bile acid secretion [6] .
Numerous reports have shown that taurine supplementation lowers serum lipid levels, particularly in animal models [7] [8] [9] [10] [11] [12] [13] . Taurine supplementation was found to improve insulin sensitivity [14] and hyperlipidemia in obese and overweight men. However, the effects of taurine supplementation on serum lipids have not as yet been defined in humans [15] [16] [17] .
In the past two decades, percentages of lean young women with a body mass index (BMI) below 18.5 kg/m2 have come to comprise more than 20 percent of women in their twenties who live in Japan [18] . This is associated with various reproductive abnormalities such as menstruation disorders, infertility and low birth weight babies [19] , such that excessively low BMI is a clinical problem requiring study and intervention.
Taurine-enriched energy drinks are now being consumed by young adults in the expectation that fatigue will be ameliorated [20, 21] . There is concern that taurine consumption might lead to malnourished states with decreasing serum lipid levels in young women. Therefore, we investigated the effects of taurine intake on blood lipoprotein lipids in healthy young women.
METHODS
Ten healthy women, all university students, with a regular menstrual cycle and the apolipoprotein E (apoE) 3/3 phenotype, were enrolled in the present study. This study was conducted according to the guidelines laid down in the Declaration of Helsinki. However, this study had already been performed before the institutional review board of Japan Women's University was established. Nonetheless, informed written consent was obtained from all study subjects after the design and objective of the study had been thoroughly explained. In addition, the present report received ethical approval from the institutional review board of Japan Women's University (No.12) prior to its submission for publication.
Each subject was instructed to orally ingest 1g of taurine powder (Taisho Pharmaceutical Co., Ltd, Tokyo, Japan) after each meal (3g/day) for one menstrual cycle. Because total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) were lower during the luteal phase than the follicular phase [22] , we set the duration of taurine intake to exclude the influences of female hormones. Such cyclic variations in lipoprotein levels may need to be considered in the design and interpretation of studies in reproductive-age women and the clinical management of cholesterol in female patients. Before and at the end of taurine intake, physical measurements and blood collection were performed in the morning after a 12-h fast.
TC, high density lipoprotein cholesterol (HDL-C), triglyceride (TG), phospholipid (PL) and free cholesterol (FC) were measured employing enzymatic methods (Kyowa Medics Determiner TC, Determiner HDL-C, Determiner TG, Determiner PL and Determiner FC, Tokyo, Japan) at the Otsuka Assay Laboratory (Tokushima, Japan). LDL-C was calculated employing Friedewald's formula [TC -HDL-C -(TG/5)]. Remnant-like particle cholesterol (RLP-C) and RLP triglyceride (RLP-TG) were measured after RLP immunoseparation using an immunoaffinity gel containing two different immobilized monoclonal antibodies to human apolipoprotein A-1 (apoA-1) and apolipoprotein B-100 at the Japanese Antibody Research Center (Gunma, Japan). ApoA-1, apolipoprotein B (apoB), and apoE were measured by immunonephelometry (Daiichi Kagaku, Apo Auto First, Tokyo, Japan) at the Otsuka Assay Laboratory (Tokushima, Japan). ApoE phenotypes were determined by isoelectric focusing followed by the immunoblotting method (Phenotyping ApoE, Jyoko, Tokyo, Japan). Lipids were extracted from serum by Folch's method [23] , and after isolation of the PL fraction by thin-layer chromatography and then methylation, fatty acids in the PL fraction were analyzed by gas chromatography (GC-12A, Shimadzu, Kyoto, Japan).
The study subjects were asked to maintain their usual lifestyles and dietary habits and to record their basal body temperature, body weight, health conditions, appetite, presence of diarrhea, amount of exercise, and alcohol intake during the experimental period. Before and at the end of the taurine intake period, 3-day weighted dietary records, which had been kept by the study subjects, were collected after confirmation by interview with a registered dietitian. Nutrient intakes were calculated employing WELLNESS/Win software (Top Business System, Okayama, Japan).
The data is expressed as mean ± standard deviation. Differences in before-and-after mean values were analyzed by the Shapiro-Wilk test. Then, normally distributed variables were analyzed by the paired t-test, and non-normally distributed variables by the Wilcoxon signedrank test. Single linear regression analyses of the changes in body weight and serum parameters before and at the end of taurine intake were conducted employing the Pearson product-moment correlation test on normally distributed variables. Differences were defined as statistically significant at p<0.05. All statistical analyses were performed using SPSS 18.0 software (SPSS Inc., Japan).
RESULTS

Subject profiles and the intakes of energy and nutrients:
The mean age of the study subjects was 21.6 ± 0.7 years, and the mean BMI was 20.0 ± 1.6 kg/m2 at baseline, indicating that the study subjects were slightly lean. The menstrual cycle length was 31.9 ± 5.2 days (range: 26-45 days), and the mean duration of taurine intake was 32.4 ± 5.3 days (range: 25-44 days). The taurine intake compliance rate was good at 98.7 ± 3.2%.
Energy and nutrient intakes including fatty acids did not differ significantly before versus at the end of the taurine intake period (Table 1) . No adverse effects were reported at any time during the experimental period. 175.47 ± 63.00 181.15 ± 50.61 P/S ratio 0.9 ± 0.3 1.1 ± 0.5 n=10; Data is presented as means ± standard deviation. Dietary records obtained 3 days before and at the end of taurine intake. SFA: Saturated fatty acid; MUFA: Mono unsaturated fatty acid; n-6 PUFA: n-6 poly unsaturated fatty acid; n-3 PUFA: n-3 poly unsaturated fatty acid; PUFA: Poly unsaturated fatty acid; P/S ratio: Polyunsaturated fatty acid/Saturated fatty acid
Changes in body weight and fasting serum lipids and apolipoprotein concentrations with taurine intake: As shown in Table 2 , as compared with the baseline values, body weight and BMI were higher at the end of taurine intake (p<0.01). In all study subjects, fasting serum lipid levels were within normal ranges at baseline. Taurine intake was associated with significant increases in TC from 4.7 ± 0.5 mmol/L to 5.2 ± 0.8 mmol/L (p<0.05) and in LDL-C from 2.7 ± 0.5 mmol/L to 3.1 ± 0.7 mmol/L (p<0.05).
Compared to the baseline, FC was significantly increased (p<0.05) and PL tended to be increased at the end of taurine intake (p=0.051). There were no differences in HDL-C, TG, RLP-C or RLP-TG between the baseline and the end of taurine intake. The TG/HDL-C ratio was unchanged. As to serum apolipoprotein concentrations, apoB increased from 0.7 ± 0.1 g/L at the baseline to 0.8 ± 0.2 g/L at the end of taurine intake (p<0.05). ApoA-I, apoE, and the apoB/apoA-I ratio did not differ between the baseline and the end of taurine intake.
Changes in the fatty acid composition of the serum PL fraction: Table 3 shows that, as compared with the baseline, all other fatty acids except for C14:0 in the serum PL fraction were increased about 1.5 fold in saturated fatty acids, 1.7 fold in C18:1, C18:2, and C 20:5, at the end of taurine intake. Correlations among changes before and at the end of taurine intake in body weight, serum lipids, apolipoproteins and fatty acid concentrations in the PL: LDL-C change showed a strong positive correlation with change in the apoB concentration (p=0.002) (Table 4 ), but not with either change in body weight or those in serum PL fatty acid concentrations (data not shown). 
DISCUSSION
In the present study, taurine intake (3 g/day) for a single menstrual cycle increased body weight, LDL-C, FC, apoB and PL fatty acid concentrations in slightly lean young women. Well-known factors that elevate serum cholesterol include increased body weight, increased energy intake and decreased energy expenditure, female hormones, and certain disorders affecting lipid metabolism. We observed no correlations among these lifestyle-related factors in terms of LDL-C change in this study.
A previous report has showed that in menstruating women, TC is higher in the follicular by 0.29 mmol/L on average than in the luteal phase of the menstrual cycle [22] . To exclude the influences of female hormones, we set the duration of taurine intake as a single menstrual cycle in each subject. Thus, the LDL-C increased with taurine supplementation was suggested to be independent of the above-described factors.
In a previous study on the influences of taurine administration on serum lipids in humans, Zang et al found that taurine supplementation decreased TG and the atherogenic index in overweight and obese adults [12] . However, Mizushima et al reported that 6 g/day taurine supplementation for 3 weeks induced significant increases in VLDL-C and TG with high fat, high cholesterol, and low polyunsaturated fatty acid / saturated fatty acid (P/S) ratio diets in healthy men [16] . Tanno et al indicated that 3.2g/day taurine supplementation while on a high cholesterol diet for 2 weeks increased serum LDL-C and biliary cholesterol levels in healthy young men [17] . The present study results in slightly lean young women are similar to those of
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previous reports, despite low cholesterol intake with a rather prolonged administration period. As is well known, LDL-C is increased by excessive intake of dietary cholesterol and saturated fatty acids, while being decreased by polyunsaturated fatty acid intake. However, since neither dietary cholesterol intake nor the P/S ratio was changed in the study subjects, the increased LDL-C and related lipid profile changes might be independent of fat intake.
In children with cystic fibrosis caused by exocrine dysfunction, extremely fatty stools associated with disorders of digestion and development, are commonly observed. Taurine administration was reported to reduce fatty stools and increase body weight under these circumstances [24, 25] . Although the digestive function of healthy persons would certainly differ from that of cystic fibrosis patients, the increase in body weight and serum lipids with taurine intake in the present study suggests that taurine might enhance fat absorption in lean women.
Additionally, we observed almost all fatty acid levels in the serum PL to be increased by at least 1.5 fold, especially in C18:1, C18:2, and C 20:5. The serum PL concentration, measured as choline derived from lecithin / lysolecithin / sphingomyelin, tended to be increased but the change did not reach statistical significance. This observation raises the possibility that PL molecules other than lecithin / lysolecithin / sphingomyelin might be increased with a significant elevation of FC. Namely, cholesterol esterification could be rather poor because of the relative increase in PL polyunsaturated fatty acids which have specificity for lecithin-cholesterol acyltransferase. Although this enzyme is key to cholesterol esterification [26] , further studies on taurine intake, as well as mass and activity data for lecithin-cholesterol acyltransferase, are needed.
We also investigated the influences of taurine intake on remnant lipoprotein levels, but no significant changes were found in either RLP-C or RLP-TG. Though the LDL-C/HDL-C ratio was increased by taurine intake, there was no significant change in the apoB/apoA-1 ratio. In addition, the LDL-C/apoB and TG/HDL-C ratios did not change in response to taurine intake. These results thus suggest that taurine intake may not increase small dense LDL, one of the atherogenic lipoproteins, despite the increased LDL-C [27, 28] . Therefore, the increase in the LDL-C/HDL-C ratio with taurine intake in this study would not be associated with atherogenic change in the lipoprotein profile.
The taurine powder (3 g/day) administered is known to be associated with a <0.5% incidence of adverse effects, such as nausea and diarrhea, but no study subjects complained in the present study. Thus, the administration of taurine powder was considered to be harmless in the study subjects.
The present study has several limitations. First, this was a non-randomized controlled study. Therefore, the present data did not clarify the mechanism accounting for the effects of taurine on serum lipids. Second, the study subjects were confined to healthy young women. Third, the study size was modest and the follow-up period was short. Based on this hypothesis-generating study, future large-scale and long-term studies should be performed. In addition, effects of taurine intake on malnourished males and elderly subjects should be tested in the future.
CONCLUSION
These results suggest that high taurine intakes from commercial foods affect lipoprotein metabolism and increase serum lipids in slightly lean young women. However, validations in
